Gupchup G V, Wolfgang A P, Thomas J
School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, IN 47907, USA.
Ann Pharmacother. 1996 Dec;30(12):1369-75. doi: 10.1177/106002809603001201.
To develop and test a questionnaire that can be used to measure directive guidance behaviors by pharmacists. QUESTIONNAIRE DESIGN: The Purdue Pharmacist Directive Guidance (PPDG) scale was developed based on the directive guidance dimension of socially supportive behaviors, as described by Barrera and Ainlay. The final scale consists of 10 items.
Individuals on the Walker Test Crew database who were 18 years of age or older and self-reported taking medications for asthma, hypertension, and/or diabetes in the past 3 months were eligible for inclusion. All data were collected through telephone interviews. A total of 464 contacts were made, resulting in 300 responses.
Principal components analysis was performed to determine the construct subscales of the PPDG. Internal consistency of the PPDG and its subscales was assessed using Cronbach's alpha and corrected item-total correlations. Pearson product-moment correlations of the PPDG with measures of family and friend support (FFS) and self-reported medication adherence were used to determine convergent validity. Spearman rank-order correlations of the PPDG with the total number of prescription medications as well as those for asthma, hypertension, and diabetes taken in the past 3 months were obtained. ANOVA and Student's t-tests were used to determine differences in PPDG across demographic characteristics.
Principal components analysis yielded two subscales for the PPDG. These were named Instruction and Feedback and Goal Setting, based on their content. The PPDG scale had good internal consistency (Cronbach's alpha = 0.86), and correlated positively and significantly with FFS (r = 0.27), giving some evidence of convergent validity. The PPDG scale and its subscales also had logically intuitive positive and significant correlations with the total number of prescription drugs taken in the past 3 months.
The PPDG is short and easy to administer, and showed validity and reliability. The PPDG scale should be useful in developing a better understanding of the process by which pharmacists influence healthcare outcomes, assessing variations in pharmaceutical care, and as a tool in identifying means of overcoming barriers to higher levels of pharmaceutical care.
开发并测试一种可用于衡量药剂师指导性指导行为的问卷。问卷设计:普渡药剂师指导性指导(PPDG)量表是基于巴雷拉和艾因利所描述的社会支持行为的指导性指导维度开发的。最终量表由10个项目组成。
沃克测试团队数据库中18岁及以上且自我报告在过去3个月内服用过哮喘、高血压和/或糖尿病药物的个体有资格纳入。所有数据通过电话访谈收集。共进行了464次联系,得到300份回复。
进行主成分分析以确定PPDG的结构子量表。使用克朗巴哈系数和校正后的项目-总分相关性评估PPDG及其子量表的内部一致性。使用PPDG与家庭和朋友支持(FFS)测量值以及自我报告的药物依从性之间的皮尔逊积矩相关性来确定收敛效度。获得了PPDG与过去3个月服用的处方药总数以及哮喘、高血压和糖尿病药物数量的斯皮尔曼等级相关性。使用方差分析和学生t检验来确定PPDG在不同人口统计学特征上的差异。
主成分分析产生了PPDG的两个子量表。根据其内容,分别命名为指导与反馈和目标设定。PPDG量表具有良好的内部一致性(克朗巴哈系数=0.86),并且与FFS呈显著正相关(r=0.27),提供了一些收敛效度的证据。PPDG量表及其子量表与过去3个月服用的处方药总数也具有符合逻辑的直观正相关且显著相关。
PPDG简短且易于实施,具有效度和信度。PPDG量表应有助于更好地理解药剂师影响医疗保健结果的过程,评估药学服务的差异,并作为识别克服更高水平药学服务障碍的方法的工具。